Investor Information

 

Theralase® Inc. is a subsidiary of Theralase® Technologies Inc., and is publicly traded on the 

  • TSX Venture Exchange (TLT-TSVX) and the
  • OTCQB (TLTFF)

Data last updated on March 14, 2019


 

Number of common shares outstanding

Basic: 146,107,042

Warrants: 35,139,705

Options: 5,770,000

Fully Diluted: 186,591,747 

Insider Ownership: 7% (9.3% fully diluted)

[stockdio-historical-chart]

Financial Filings

 
Downloaded 267 times.
Downloaded 253 times.
Downloaded 170 times.
Downloaded 92 times.
Downloaded 54 times.
Downloaded 8 times.
Downloaded 9 times.
Downloaded 10 times.
Downloaded 0 times.
Downloaded 0 times.
Downloaded 2 times.
Downloaded 2 times.
Downloaded 0 times.
Downloaded 0 times.
Downloaded 0 times.
Downloaded 1 times.
Downloaded 2 times.
Downloaded 0 times.
Downloaded 1 times.
Downloaded 1 times.
Downloaded 0 times.
Downloaded 0 times.
Downloaded 3 times.
 
Downloaded 131 times.
Downloaded 116 times.
Downloaded 78 times.
Downloaded 43 times.
Downloaded 38 times.
Downloaded 4 times.
Downloaded 5 times.
Downloaded 6 times.
Downloaded 0 times.
Downloaded 3 times.
Downloaded 0 times.
Downloaded 2 times.
Downloaded 0 times.
Downloaded 0 times.
Downloaded 0 times.
Downloaded 3 times.
Downloaded 0 times.
Downloaded 0 times.
Downloaded 0 times.
Downloaded 0 times.
Downloaded 0 times.
Downloaded 0 times.
Downloaded 5 times.
SEDAR Filings (System for Electronic Document Analysis and Retrieval)

Theralase's complete public securities documents are available in English and French on SEDAR.